Previous 10 | Next 10 |
NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of central nervous system disease...
This week, there are plenty of penny stocks to buy, and this article discusses some of the cheapest names on the block. It’s important to remember that just because something is considered “cheap” doesn’t necessarily mean it’s worth the risk. The opposite ...
EB-101 pivotal phase 3 VIITAL™ study in RDEB achieves target enrollment; top-line data expected in third quarter of 2022; gained FDA alignment on CMC requirements for EB-101 including characterization and validation plans Company to focus R&D resources primarily on VI...
3 Biotech Penny Stocks to Watch in March 2022 Buying penny stocks be a great investment opportunity, but it’s important to understand the risks before you invest. With so many penny stocks to choose from, it can be difficult to find the best ones to buy. And when it comes to ...
Buying Penny Stocks Today? Here’s What You Need to Know With more news affecting penny stocks and blue chips right now than in many weeks prior, there is a lot for investors to consider. Of course, the major issues in the market right now include Fed interest rate hikes and the i...
Gainers: Avenue Therapeutics (NASDAQ:ATXI) +165%. CTI BioPharma (NASDAQ:CTIC) +60%. UserTesting (NYSE:USER) +31%. Oak Street Health (NYSE:OSH) +25%. iQIYI (NASDAQ:IQ) +24%. Veritiv (NYSE:VRTV) +18%. TaskUs (NASDAQ:TASK) +17%. Danimer Scientific (NYSE:DNMR) +17%. LivePerson (NASDAQ:LPSN) +16%....
Are you looking for cheap stocks to buy? Penny stocks are one place to start. According to the standard definition, we’re talking about stocks trading below $5 per share. Outside of any other facet, much of the risk of penny stocks involves their price, in general. It also lends ...
Nano-cap stock Avenue Therapeutics (ATXI +217.7%) has more than trebled in value on above average volume in morning hours on Tuesday. The sudden investor interest in the development stage pharmaceutical company has triggered several trading halts for volatility. Currently about ~121.4M Avenue...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It’s time to get into the thick of it with the biggest pre-market stock movers for Tuesday! Source: Eric Urquhart/Shutterstock.com Moving stocks this morning are reverse stock splits, ...
A majority of an FDA advisory committee agreed that Avenue Therapeutics (NASDAQ:ATXI) had not submitted adequate information to support the position that the benefits of intravenous (“IV”) tramadol outweighed the risks. The company announced the outcome of the U.S...
News, Short Squeeze, Breakout and More Instantly...
Avenue Therapeutics Inc. Company Name:
ATXI Stock Symbol:
NASDAQ Market:
Avenue Therapeutics Inc. Website:
MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced tha...
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the ...
– Raised a total of $9.4 million in gross proceeds from warrant exercise transactions since January 2024 – MIAMI, May 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutica...